Welcome to LookChem.com Sign In|Join Free
  • or
1-Methyl-1H-pyrazol-3-amine is an organic compound that serves as a crucial intermediate in the synthesis of various chemical and pharmaceutical products. It is a colorless to light yellow liquid with unique chemical properties that make it valuable in different industries.

1904-31-0

Post Buying Request

1904-31-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1904-31-0 Usage

Uses

Used in Organic Synthesis:
1-Methyl-1H-pyrazol-3-amine is used as a key intermediate for the synthesis of various organic compounds. Its unique chemical structure allows for the creation of a wide range of products, making it an essential component in this field.
Used in Pharmaceuticals:
In the pharmaceutical industry, 1-Methyl-1H-pyrazol-3-amine is used as a building block for the development of new drugs. Its versatile chemical properties enable the design and synthesis of innovative pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemicals:
1-Methyl-1H-pyrazol-3-amine is also utilized as a raw material in the agrochemical sector. It plays a vital role in the development of new agrochemical products, such as pesticides and herbicides, that are essential for maintaining agricultural productivity and crop protection.
Used in Dyestuff:
In the dyestuff industry, 1-Methyl-1H-pyrazol-3-amine is employed as an important intermediate for the production of various dyes and pigments. Its unique chemical properties contribute to the development of new and improved colorants for various applications, including textiles, plastics, and printing inks.

Check Digit Verification of cas no

The CAS Registry Mumber 1904-31-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,0 and 4 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1904-31:
(6*1)+(5*9)+(4*0)+(3*4)+(2*3)+(1*1)=70
70 % 10 = 0
So 1904-31-0 is a valid CAS Registry Number.
InChI:InChI=1/C4H7N3/c1-7-3-2-4(5)6-7/h2-3H,1H3,(H2,5,6)

1904-31-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H30935)  3-Amino-1-methyl-1H-pyrazole, 97%   

  • 1904-31-0

  • 1g

  • 357.0CNY

  • Detail
  • Alfa Aesar

  • (H30935)  3-Amino-1-methyl-1H-pyrazole, 97%   

  • 1904-31-0

  • 5g

  • 1190.0CNY

  • Detail

1904-31-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Methyl-1H-pyrazol-3-amine

1.2 Other means of identification

Product number -
Other names 1-METHYL-1H-PYRAZOL-3-YLAMINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1904-31-0 SDS

1904-31-0Synthetic route

1-methyl-3-nitro-1H-pyrazole
54210-32-1

1-methyl-3-nitro-1H-pyrazole

A

1,1'-dimethyl-3-azoxypyrazole
132038-69-8

1,1'-dimethyl-3-azoxypyrazole

B

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

Conditions
ConditionsYield
With hydrazine hydrate; nickel In ethanol Heating;A 54%
B 7.1 g
4-iodo-1-methyl-3-nitro-1H-pyrazole
75092-34-1

4-iodo-1-methyl-3-nitro-1H-pyrazole

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride In water at 30℃; for 2h; Reduction;51%
N-(1-methyl-3-pyrazolyl)-acetoacetamide
91027-92-8

N-(1-methyl-3-pyrazolyl)-acetoacetamide

A

2,4-dimethyl-2H-pyrazolo<3,4-b>pyridin-6(7H)-one
73810-75-0

2,4-dimethyl-2H-pyrazolo<3,4-b>pyridin-6(7H)-one

B

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

Conditions
ConditionsYield
With hydrogenchloride In ethanol for 3h; Heating;A 21%
B 15%
1-methyl-3-nitro-1H-pyrazole
54210-32-1

1-methyl-3-nitro-1H-pyrazole

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride Reduction;
With hydrogen In methanol for 3h;
pivaloyl chloride
3282-30-2

pivaloyl chloride

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

C9H15N3O
1135343-82-6

C9H15N3O

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0 - 20℃;100%
acetyl chloride
75-36-5

acetyl chloride

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

N-(1-methyl-1H-pyrazol-3-yl)-acetamide hydrochlorid

N-(1-methyl-1H-pyrazol-3-yl)-acetamide hydrochlorid

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 2h;100%
In tetrahydrofuran at 0 - 20℃; for 2h;100%
3-(chlorosulfonyl)benzenesulfonyl fluoride
2489-52-3

3-(chlorosulfonyl)benzenesulfonyl fluoride

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

3-(N-(1-methyl-1H-pyrazol-3-yl)sulfamoyl)benzene-1-sulfonyl fluoride

3-(N-(1-methyl-1H-pyrazol-3-yl)sulfamoyl)benzene-1-sulfonyl fluoride

Conditions
ConditionsYield
With pyridine In chloroform at 20℃; for 48h; chemoselective reaction;99%
4-(chlorosulfonyl)benzenesulfonyl fluoride

4-(chlorosulfonyl)benzenesulfonyl fluoride

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

C10H10FN3O4S2

C10H10FN3O4S2

Conditions
ConditionsYield
With pyridine In chloroform at 20℃; for 48h; chemoselective reaction;99%
bromochlorobenzene
106-39-8

bromochlorobenzene

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

N-(4-chlorophenyl)-1-methyl-1H-pyrazol-3-amine

N-(4-chlorophenyl)-1-methyl-1H-pyrazol-3-amine

Conditions
ConditionsYield
With copper(l) iodide; N-(2,6-dimethylphenyl)-6-hydroxypicolinamide; potassium carbonate In dimethyl sulfoxide at 110℃;99%
2,5-hexanedione
110-13-4

2,5-hexanedione

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-methyl-1H-pyrazole
34605-66-8

3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-methyl-1H-pyrazole

Conditions
ConditionsYield
toluene-4-sulfonic acid In toluene for 4h; Reflux;98%
With acetic acid In toluene at 155℃;98.1%
With toluene-4-sulfonic acid In benzene at 115℃; for 4h;94%
methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-methyl-1H-pyrazole
34605-66-8

3-(2,5-dimethyl-1H-pyrrol-1-yl)-1-methyl-1H-pyrazole

Conditions
ConditionsYield
With acetic acid In toluene at 155℃;98.1%
1-(2-bromophenyl)pyrazole

1-(2-bromophenyl)pyrazole

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

N-(2-(1H-pyrazol-1-yl)phenyl)-1-methyl-1H-pyrazol-3-amine

N-(2-(1H-pyrazol-1-yl)phenyl)-1-methyl-1H-pyrazol-3-amine

Conditions
ConditionsYield
With copper(l) iodide; N-(2,6-dimethylphenyl)-6-hydroxypicolinamide; potassium carbonate In dimethyl sulfoxide at 110℃;98%
6-bromo-2-methoxypyridine
40473-07-2

6-bromo-2-methoxypyridine

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

6-methoxy-N-(1-methyl-1H-pyrazol-3-yl)pyridin-2-amine

6-methoxy-N-(1-methyl-1H-pyrazol-3-yl)pyridin-2-amine

Conditions
ConditionsYield
With copper(l) iodide; N-(2,6-dimethylphenyl)-6-hydroxypicolinamide; potassium carbonate In dimethyl sulfoxide at 110℃;98%
4-chloro-7-isothiocyanato-7-de(acetamide)colchicine
1267993-72-5

4-chloro-7-isothiocyanato-7-de(acetamide)colchicine

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

4-chloro-N-[(1-methylpyrazole-3-yl)thiocarbamoyl]deacetyl colchicine
1267992-51-7

4-chloro-N-[(1-methylpyrazole-3-yl)thiocarbamoyl]deacetyl colchicine

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 80℃; for 2h; Inert atmosphere;96%
methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

1-methyl-1H-pyrazole-3-diazonium haxafluorophosphate

1-methyl-1H-pyrazole-3-diazonium haxafluorophosphate

Conditions
ConditionsYield
With hexafluorophosphoric acid; isopentyl nitrite In methanol at -20℃; for 1h;95%
5-chloro-2-methylphenylisothiocyanate
19241-36-2

5-chloro-2-methylphenylisothiocyanate

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

1-(5-chloro-2-methyl-phenyl)-3-(1-methyl-1H-pyrazol-3-yl)-thiourea
221089-29-8

1-(5-chloro-2-methyl-phenyl)-3-(1-methyl-1H-pyrazol-3-yl)-thiourea

Conditions
ConditionsYield
95%
(E)-(3-chloro-4-methanesulfonyl-phenyl)-isobutoxyimino-acetic acid
1033780-31-2

(E)-(3-chloro-4-methanesulfonyl-phenyl)-isobutoxyimino-acetic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

(E)-2-(3-chloro-4-methanesulfonyl-phenyl)-2-isobutoxyimino-N-(1-methyl-1H-pyrazol-3-yl)-acetamide
1033780-09-4

(E)-2-(3-chloro-4-methanesulfonyl-phenyl)-2-isobutoxyimino-N-(1-methyl-1H-pyrazol-3-yl)-acetamide

Conditions
ConditionsYield
Stage #1: (E)-(3-chloro-4-methanesulfonyl-phenyl)-isobutoxyimino-acetic acid; methyl-1 amino-3 pyrazole With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 0℃; for 2h;
Stage #2: With sodium hydrogencarbonate In water
95%
2-chloro-5-fluoro-4-(3-nitrophenoxy)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine
1428775-55-6

2-chloro-5-fluoro-4-(3-nitrophenoxy)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

5-fluoro-N-(1-methyl-1H-pyrazol-3-yl)-4-(3-nitrophenoxy)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine
1428775-56-7

5-fluoro-N-(1-methyl-1H-pyrazol-3-yl)-4-(3-nitrophenoxy)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In 1,4-dioxane at 140℃; for 0.75h; Inert atmosphere; Microwave irradiation;95%
bis(2,4,6-trichlorophenyl) 2-(3,5-dichlorophenyl)propanedioate

bis(2,4,6-trichlorophenyl) 2-(3,5-dichlorophenyl)propanedioate

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

6-(3,5-dichlorophenyl)-5-hydroxy-1-methylpyrazolo[1,5-a]pyrimidin-7-one

6-(3,5-dichlorophenyl)-5-hydroxy-1-methylpyrazolo[1,5-a]pyrimidin-7-one

Conditions
ConditionsYield
In toluene for 1h; Reflux;94%
methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

4-iodo-1-methyl-3-amino-1H-pyrazole

4-iodo-1-methyl-3-amino-1H-pyrazole

Conditions
ConditionsYield
With dihydrogen peroxide; iodine In ethanol; water at 15 - 35℃; for 6h;93.1%
methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

5-methylpyrazolodithiazolium chloride
89088-58-4

5-methylpyrazolodithiazolium chloride

Conditions
ConditionsYield
With disulfur dichloride In acetic acid 1) 0 deg C to ambient temp. 2) up to 65 deg C, 3h 3) 65 deg C, 2h;93%
2-(1-((tert-butoxycarbonyl)amino)cyclobutyl)-2-hydroxyacetic acid
1232365-39-7

2-(1-((tert-butoxycarbonyl)amino)cyclobutyl)-2-hydroxyacetic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

{1-[hydroxy-(1-methyl-1H-pyrazol-3-ylcarbamoyl)methyl]cyclobutyl}carbamic acid tert-butyl ester
1232365-56-8

{1-[hydroxy-(1-methyl-1H-pyrazol-3-ylcarbamoyl)methyl]cyclobutyl}carbamic acid tert-butyl ester

Conditions
ConditionsYield
Stage #1: 2-(1-((tert-butoxycarbonyl)amino)cyclobutyl)-2-hydroxyacetic acid; methyl-1 amino-3 pyrazole With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: With HATU In N,N-dimethyl-formamide at 20℃; for 2h;
92%
Stage #1: 2-(1-((tert-butoxycarbonyl)amino)cyclobutyl)-2-hydroxyacetic acid; methyl-1 amino-3 pyrazole With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: With HATU In N,N-dimethyl-formamide at 20℃; for 2h;
92%
2-(1-(tert-butoxycarbonylamino)-3,3-difluorocyclobutyl)-2-hydroxyacetic acid
1232365-45-5

2-(1-(tert-butoxycarbonylamino)-3,3-difluorocyclobutyl)-2-hydroxyacetic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

{3,3-difluoro-1-[hydroxy-(1-methyl-1H-pyrazol-3-ylcarbamoyl)methyl]cyclobutyl}carbamic acid tert-butyl ester
1311321-33-1

{3,3-difluoro-1-[hydroxy-(1-methyl-1H-pyrazol-3-ylcarbamoyl)methyl]cyclobutyl}carbamic acid tert-butyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 0 - 20℃; for 2h;92%
ethyl (2-chloroaceto)acetate
638-07-3

ethyl (2-chloroaceto)acetate

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

5-Chloromethyl-1-methyl-1H-pyrazolo[1,5-a]pyrimidin-7-one
104164-03-6

5-Chloromethyl-1-methyl-1H-pyrazolo[1,5-a]pyrimidin-7-one

Conditions
ConditionsYield
With PPA at 100℃;91%
3-[(1S)-2-tert-butoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]benzoic acid
883907-39-9

3-[(1S)-2-tert-butoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]benzoic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

3-[(1S)-2-tert-butoxy-1-methylethoxy]-N-(1-methyl-1H-pyrazol-3-yl)-5-[4-(methylsulfonyl)phenoxy]benzamide
883907-34-4

3-[(1S)-2-tert-butoxy-1-methylethoxy]-N-(1-methyl-1H-pyrazol-3-yl)-5-[4-(methylsulfonyl)phenoxy]benzamide

Conditions
ConditionsYield
Stage #1: 3-[(1S)-2-tert-butoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]benzoic acid With 1,1'-carbonyldiimidazole In acetonitrile at 25℃; for 2h;
Stage #2: methyl-1 amino-3 pyrazole In acetonitrile at 60℃; for 18h; Product distribution / selectivity;
91%
Stage #1: 3-[(1S)-2-tert-butoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]benzoic acid With 1,1'-carbonyldiimidazole In tetrahydrofuran at 20℃; for 1.08333h;
Stage #2: methyl-1 amino-3 pyrazole In tetrahydrofuran; toluene at 60℃; for 18h; Product distribution / selectivity;
3-[4-(azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-tert-butoxy-1-methylethoxy]benzoic acid
937842-58-5

3-[4-(azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-tert-butoxy-1-methylethoxy]benzoic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

3-[4-(Azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-tert-butoxy-1-methylethoxy]-N-(1-methyl-1H-pyrazol-3-yl)benzamide
937842-59-6

3-[4-(Azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-tert-butoxy-1-methylethoxy]-N-(1-methyl-1H-pyrazol-3-yl)benzamide

Conditions
ConditionsYield
Stage #1: 3-[4-(azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-tert-butoxy-1-methylethoxy]benzoic acid With 4-methyl-morpholine; 2-chloro-4,6-dimethoxy-1 ,3,5-triazine In acetonitrile at 0 - 20℃; for 1.3h;
Stage #2: methyl-1 amino-3 pyrazole In acetonitrile at 20℃; for 0.333333h; Product distribution / selectivity;
90%
Stage #1: 3-[4-(azetidin-1-ylcarbonyl)phenoxy]-5-[(1S)-2-tert-butoxy-1-methylethoxy]benzoic acid With 1,1'-carbonyldiimidazole In acetonitrile at 25℃; for 1.08333h;
Stage #2: methyl-1 amino-3 pyrazole In acetonitrile at 50℃; Product distribution / selectivity;
89%
methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

4-bromo-1-methyl-1H-pyrazol-3-ylamine
146941-72-2

4-bromo-1-methyl-1H-pyrazol-3-ylamine

Conditions
ConditionsYield
With bromine In ethanol at 0 - 15℃; for 1h;89.4%
With sodium hydroxide; bromine In dichloromethane; water
3-bromo-4-methylbenzoic acid
7697-26-9

3-bromo-4-methylbenzoic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

3 -bromo-4-methyl-N-(1-methyl-1H-pyrazol-3-yl)benzamide

3 -bromo-4-methyl-N-(1-methyl-1H-pyrazol-3-yl)benzamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 15℃; for 12h;89.2%
ortho-bromophenylacetic acid
18698-97-0

ortho-bromophenylacetic acid

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

2-(2-bromophenyl)-N-(1-methyl-1H-pyrazol-3-yl)acetamide
1609551-50-9

2-(2-bromophenyl)-N-(1-methyl-1H-pyrazol-3-yl)acetamide

Conditions
ConditionsYield
Stage #1: ortho-bromophenylacetic acid With oxalyl dichloride In dichloromethane at 0 - 20℃; for 2h;
Stage #2: methyl-1 amino-3 pyrazole In dichloromethane at 0 - 20℃;
88%
6-chloro-4-(2-methylpyridin-4-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile

6-chloro-4-(2-methylpyridin-4-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

6-[(1-methyl-1H-pyrazol-3-yl)amino]-4-(2-methylpyridin-4-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile

6-[(1-methyl-1H-pyrazol-3-yl)amino]-4-(2-methylpyridin-4-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene; sodium t-butanolate In toluene at 90℃; for 18h; Buchwald-Hartwig Coupling; Inert atmosphere; Sealed tube;88%
ethyl 4,4,4-trifluoroacetoacetate
372-31-6

ethyl 4,4,4-trifluoroacetoacetate

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

4-trifluoromethyl-6-hydroxy-2-methylpyrazolo<3,4-b>pyridine

4-trifluoromethyl-6-hydroxy-2-methylpyrazolo<3,4-b>pyridine

Conditions
ConditionsYield
In acetic acid for 4h; Heating;87.4%
di(tert-butyl)chlorophosphine
13716-10-4

di(tert-butyl)chlorophosphine

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

P,P-di(tert-butyl)-N-(1-methyl-1H-pyrazol-3-yl)phosphinous amide
1367863-21-5

P,P-di(tert-butyl)-N-(1-methyl-1H-pyrazol-3-yl)phosphinous amide

Conditions
ConditionsYield
With triethylamine at 125℃; for 72h; Inert atmosphere;87%
2-[(3-bromo-4-nitrophenoxy)methyl]quinoline

2-[(3-bromo-4-nitrophenoxy)methyl]quinoline

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

1-methyl-N-[2-nitro-5-(quinolin-2-ylmethoxy)phenyl]-1H-pyrazol-3-amine

1-methyl-N-[2-nitro-5-(quinolin-2-ylmethoxy)phenyl]-1H-pyrazol-3-amine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In toluene at 85℃; for 2h; Buchwald-Hartwig Coupling; Inert atmosphere;87%
tert-butyl {3-[(2-chloro-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}carbamate
1428775-59-0

tert-butyl {3-[(2-chloro-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}carbamate

methyl-1 amino-3 pyrazole
1904-31-0

methyl-1 amino-3 pyrazole

tert-butyl (3-((2-((1-methyl-1H-pyrazol-3-yl)amino)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)carbamate

tert-butyl (3-((2-((1-methyl-1H-pyrazol-3-yl)amino)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)carbamate

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); caesium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In 1,4-dioxane at 140℃; for 0.75h; Buchwald-Hartwig Coupling; Microwave irradiation;87%

1904-31-0Relevant academic research and scientific papers

Synthesis of vicinal aminoiodo- and (acetylamino)iodo-1-alkylpyrazoles

Tret'yakov,Vasilevsky

, p. 2585 - 2587 (1996)

3- and 5-(Acetylamino)-4-iodo-1-alkylpyrazoles were obtained by successive acylation and iodination from 3- and 5-amino-1-alkylpyrazoles without isolating intermediate (acetylamino)pyrazoles. 3- and 5-Iodo- and 3,5-diiodo-4-amino-1-methylpyrazoles were synthesized from appropriate iodonitropyrazoles by reduction with SnCl2 in HCl.

Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives

Zheng, Ke,Iqbal, Sarah,Hernandez, Pamela,Park, Hajeung,Lograsso, Philip V.,Feng, Yangbo

supporting information, p. 10013 - 10030 (2015/02/19)

The c-jun N-terminal kinase 3 (JNK3) is expressed primarily in the brain. Numerous reports have shown that inhibition of JNK3 is a promising strategy for treatment of neurodegeneration. The optimization of aminopyrazole-based JNK3 inhibitors with improved potency, isoform selectivity, and pharmacological properties by structure-activity relationship (SAR) studies utilizing biochemical and cell-based assays, and structure-based drug design is reported. These inhibitors had high selectivity over JNK1 and p38α, minimal cytotoxicity, potent inhibition of 6-OHDA-induced mitochondrial membrane potential dissipation and ROS generation, and good drug metabolism and pharmacokinetic (DMPK) properties for iv dosing. 26n was profiled against 464 kinases and was found to be highly selective hitting only seven kinases with >80% inhibition at 10 μM. Moreover, 26n showed good solubility, good brain penetration, and good DMPK properties. Finally, the crystal structure of 26k in complex with JNK3 was solved at 1.8 ? to explore the binding mode of aminopyrazole based JNK3 inhibitors.

STUDIES IN THE FIELD OF NITROGEN HETEROCYCLIC COMPOUNDS. PART X. SYNTHESIS AND NEW RING TRANSFORMATION OF SOME FUSED PYRAZOLE SYSTEMS

Balicki, Roman

, p. 1273 - 1278 (2007/10/02)

Condensation of 3-amino-1-methylpyrazole (7) with ethyl acetoacetate (1) in ethanol leads to formation of aminocrotonate 8, whereas the reaction in Dowtherm A above 200 deg C gives acetoacetamide (9).Ring closure of 8 in polyphosphoric acid (PPA) or ethanolic hydrochloride gives pyrazolopyrimidine (10).However, in Dowtherm A besides compound 10, the pyrazolopyridine (11) is also formed.Heating of 10 in Dowtherm A at 220-240 deg C causes ring transformation into 11.In acetic acid, compound 8 undergoes rearrangement to acetoacetamide 9 prior to cyclization into pyrazolopyridine (12).The structures of the compounds obtained were deduced from their IR, MS, 1H NMR and 13C NMR spectra.Pathways of the reactions presented are also discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1904-31-0